KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Co-Diagnostics (CODX) Return on Capital Employed (2017 - 2025)

Historic Return on Capital Employed for Co-Diagnostics (CODX) over the last 9 years, with Q3 2025 value amounting to 0.85%.

  • Co-Diagnostics' Return on Capital Employed fell 2800.0% to 0.85% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.85%, marking a year-over-year decrease of 2800.0%. This contributed to the annual value of 0.55% for FY2024, which is 1400.0% down from last year.
  • Per Co-Diagnostics' latest filing, its Return on Capital Employed stood at 0.85% for Q3 2025, which was down 2800.0% from 0.82% recorded in Q2 2025.
  • Over the past 5 years, Co-Diagnostics' Return on Capital Employed peaked at 0.74% during Q1 2021, and registered a low of 0.85% during Q3 2025.
  • Its 5-year average for Return on Capital Employed is 0.2%, with a median of 0.44% in 2023.
  • As far as peak fluctuations go, Co-Diagnostics' Return on Capital Employed soared by 13000bps in 2021, and later crashed by -7000bps in 2023.
  • Quarter analysis of 5 years shows Co-Diagnostics' Return on Capital Employed stood at 0.38% in 2021, then crashed by -153bps to 0.21% in 2022, then plummeted by -116bps to 0.44% in 2023, then plummeted by -48bps to 0.66% in 2024, then dropped by -29bps to 0.85% in 2025.
  • Its Return on Capital Employed was 0.85% in Q3 2025, compared to 0.82% in Q2 2025 and 0.71% in Q1 2025.